As the popularity of Ozempic, a medication used to treat type 2 diabetes and promote weight loss, continues to grow within the pharmaceutical market, it is having a ripple effect on various sectors within the US retail market. This report, exclusive to subscribers only, explores the potential impact of GLP-1 drugs on companies such as Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo and Walmart.
Subscribers can log in to access this document and gain valuable insights into how widespread GLP-1 drug use is affecting different sectors of the retail industry. The report highlights the importance of prioritizing health and wellness for consumers and how this trend is driving demand for medications like Ozempic.
If you are not a subscriber yet, you can learn more about subscriptions and access to relevant research that will help you stay informed about this topic. Don’t miss out on this exclusive opportunity to gain valuable insights into the effects of GLP-1 drugs on the retail industry.